BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 22336863)

  • 1. Different magnesium sulphate regimens for neuroprotection of the fetus for women at risk of preterm birth.
    Bain E; Middleton P; Crowther CA
    Cochrane Database Syst Rev; 2012 Feb; (2):CD009302. PubMed ID: 22336863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnesium sulphate for women at term for neuroprotection of the fetus.
    Nguyen TM; Crowther CA; Wilkinson D; Bain E
    Cochrane Database Syst Rev; 2013 Feb; (2):CD009395. PubMed ID: 23450601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus.
    Doyle LW; Crowther CA; Middleton P; Marret S
    Cochrane Database Syst Rev; 2007 Jul; (3):CD004661. PubMed ID: 17636771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus.
    Doyle LW; Crowther CA; Middleton P; Marret S; Rouse D
    Cochrane Database Syst Rev; 2009 Jan; (1):CD004661. PubMed ID: 19160238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No. 376-Magnesium Sulphate for Fetal Neuroprotection.
    Magee LA; De Silva DA; Sawchuck D; Synnes A; von Dadelszen P
    J Obstet Gynaecol Can; 2019 Apr; 41(4):505-522. PubMed ID: 30879485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the neuroprotective benefits for babies of antenatal magnesium sulphate: An individual participant data meta-analysis.
    Crowther CA; Middleton PF; Voysey M; Askie L; Duley L; Pryde PG; Marret S; Doyle LW;
    PLoS Med; 2017 Oct; 14(10):e1002398. PubMed ID: 28976987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Creatine for women in pregnancy for neuroprotection of the fetus.
    Dickinson H; Bain E; Wilkinson D; Middleton P; Crowther CA; Walker DW
    Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD010846. PubMed ID: 25523279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SOGC Clinical Practice Guideline. Magnesium sulphate for fetal neuroprotection.
    Magee L; Sawchuck D; Synnes A; von Dadelszen P; ;
    J Obstet Gynaecol Can; 2011 May; 33(5):516-529. PubMed ID: 21639972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melatonin for women in pregnancy for neuroprotection of the fetus.
    Wilkinson D; Shepherd E; Wallace EM
    Cochrane Database Syst Rev; 2016 Mar; 3(3):CD010527. PubMed ID: 27022888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnesium sulphate for preventing preterm birth in threatened preterm labour.
    Crowther CA; Hiller JE; Doyle LW
    Cochrane Database Syst Rev; 2002; (4):CD001060. PubMed ID: 12519550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnesium sulphate for fetal neuroprotection at imminent risk for preterm delivery: a systematic review with meta-analysis and trial sequential analysis.
    Wolf HT; Huusom LD; Henriksen TB; Hegaard HK; Brok J; Pinborg A
    BJOG; 2020 Sep; 127(10):1180-1188. PubMed ID: 32237069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antenatal magnesium sulphate neuroprotection in the preterm infant.
    Marret S; Doyle LW; Crowther CA; Middleton P
    Semin Fetal Neonatal Med; 2007 Aug; 12(4):311-7. PubMed ID: 17513184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnesium sulphate at 30 to 34 weeks' gestational age: neuroprotection trial (MAGENTA)--study protocol.
    Crowther CA; Middleton PF; Wilkinson D; Ashwood P; Haslam R;
    BMC Pregnancy Childbirth; 2013 Apr; 13():91. PubMed ID: 23570677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnesium maintenance therapy for preventing preterm birth after threatened preterm labour.
    Han S; Crowther CA; Moore V
    Cochrane Database Syst Rev; 2010 Jul; (7):CD000940. PubMed ID: 20614423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neuroprotection for preterm infants with antenatal magnesium sulphate].
    Marret S; Ancel PY
    J Gynecol Obstet Biol Reprod (Paris); 2016 Dec; 45(10):1418-1433. PubMed ID: 28166926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative magnesium sulphate regimens for women with pre-eclampsia and eclampsia.
    Duley L; Matar HE; Almerie MQ; Hall DR
    Cochrane Database Syst Rev; 2010 Aug; 2010(8):CD007388. PubMed ID: 20687086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal adverse effects with different loading infusion rates of antenatal magnesium sulphate for preterm fetal neuroprotection: the IRIS randomised trial.
    Bain ES; Middleton PF; Yelland LN; Ashwood PJ; Crowther CA
    BJOG; 2014 Apr; 121(5):595-603. PubMed ID: 24387624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of antenatal magnesium sulphate on MRI biomarkers of white matter development at term equivalent age: The MagNUM Study.
    Poppe T; Thompson B; Boardman JP; Bastin ME; Alsweiler J; Deib G; Harding JE; Crowther CA;
    EBioMedicine; 2022 Apr; 78():103923. PubMed ID: 35331677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antenatal magnesium sulfate and neuroprotection.
    Doyle LW
    Curr Opin Pediatr; 2012 Apr; 24(2):154-9. PubMed ID: 22227787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relaxin for preventing preterm birth.
    Bain E; Heatley E; Hsu K; Crowther CA
    Cochrane Database Syst Rev; 2013 Aug; (8):CD010073. PubMed ID: 23949874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.